The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Lipid Metabolism and Insulin Resistance in Depressed Patients: Significance of Weight, Hypercortisolism, and Antidepressant Treatment
Abstract
Major depression increases cardiovascular risk despite lower cholesterol levels. Little is known about effects of antidepressants on metabolic risk factors. We studied lipoprotein composition, insulin sensitivity (quantitative insulin sensitivity check index), and saliva cortisol in 78 depressed patients before and after 35 days of amitriptyline or paroxetin treatment. Data were analyzed by principal component factor analyses and analysis of variance (ANOVA). At baseline, quantitative insulin sensitivity check index was inversely correlated with cortisol (r = −0.46; P = 0.005) in normal weight patients, with body mass index in overweight patients (r = −0.50; P < 0.001). In overweight patients, hypercortisolemia correlated inversely with total and low density lipoprotein cholesterol (eg, cortisol at 4:00 PM and low density lipoprotein cholesterol: r = −0.49, P = 0.002). After treatment, quantitative insulin sensitivity check index was unchanged. Triglycerides increased in responders to amitriptyline only (P < 0.05). Parameters of cholesterol metabolism improved slightly without differences between treatment groups (eg, high density lipoprotein: pre 43.5 ± 12.0; post 47.6 ± 13.0 mg/dL; P = 0.01; low density lipoprotein triglycerides, a measure of low density lipoprotein atherogenicity: pre 458 ± 120; post 415 ± 130 mg/g; P < 0,01). The inverse correlation of cortisol and cholesterol, at least in the obese subgroup, proposes a mechanism for the known association of depression with low cholesterol. As determinants of plasma lipids in major depression, we identified body mass index, insulin sensitivity, and cortisol. Although uncontrolled, our data suggest that treatment of depression exerts a mainly beneficial effect on lipid regulation. Abbreviations: AMI = amitriptyline, BMI = body mass index, DSM IV = Diagnostic and Statistical Manual, IVth revision, HAMD = hamilton depression scale,HDL= high density lipoprotein, hypothalamus-pituitaryadrenal axis, LDL = low density lipoprotein, PAR = paroxetin, PPARa = peroxisome proliferation activator receptor a, QUICKI = quantitative insulin sensitivity check index, SSRI = selective serotonine reuptake inhibitor, TCA = tricyclic antidepressant, VLDL = very low density lipoprotein.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Amitriptyline therapy increases TG levels.
“Kopf et al. [146] have also demonstrated the increase in TG levels following their amitriptyline therapy.”
From Lipids in Psychiatric Disorders: Functional and Potential Diagnostic Role as Blood Biomarkers (2024) · cites this paper as [146]
Citations
Cites
Depressed Affect, Hopelessness, and the Risk of Ischemic Heart Disease in a Cohort of U.S. Adults
Anda, R. F., Williamson, D. F., Jones, D., Macera, C., Eaker, E. D., Glassman, A. H., & Marks, J. S. (1993) · Epidemiology · doi:10.1097/00001648-199307000-00003 · Cited by 770
Association Between Depression and Mortality in Older Adults
Schulz, R., Beach, S. R., Ives, D. G., Martire, L. M., Ariyo, A. A., & Kop, W. J. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.12.1761 · Cited by 611
Hopelessness and Risk of Mortality and Incidence of Myocardial Infarction and Cancer
Everson‐Rose, S. A., Goldberg, D. E., Kaplan, G. A., Cohen, R. D., Pukkala, ., Tuomilehto, J., & Salonen, J. T. (1996) · Psychosomatic Medicine · doi:10.1097/00006842-199603000-00003 · Cited by 591
Depression as an Antecedent to Heart Disease Among Women and Men in the NHANES I Study
Ferketich, A. K., Schwartzbaum, J., Frid, D. J., & Moeschberger, M. L. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.9.1261 · Cited by 490
Lamarche, B. (1998) · JAMA · doi:10.1001/jama.279.24.1955 · Cited by 418
Lemberger, T., Saladin, R., Vázquez‐Carrera, M., Assimacopoulos, F., Staels, B., Desvergne, B., Wahli, W., & Auwerx, J. H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.3.1764 · Cited by 329
Okamura, F., Tashiro, A., Utumi, A., Imai, T., Suchi, T., Tamura, D., Sato, Y., Suzuki, S., & Hongo, M. (2000) · Metabolism · doi:10.1053/meta.2000.9515 · Cited by 242
Hypercortisolemic Depression Is Associated With Increased Intra-Abdominal Fat
Weber-Hamann, B., Hentschel, F., Kniest, A., Deuschle, M., Colla, M., Lederbogen, F., & Heuser, I. (2002) · Psychosomatic Medicine · doi:10.1097/00006842-200203000-00010 · Cited by 219
Self-citationThakore, J. H., Richards, P. J., Reznek, R. H., Martin, A., & Dinan, T. G. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(97)85394-2 · Cited by 167
Current concepts in insulin resistance, type 2 diabetes mellitus, and the metabolic syndrome
Reusch, J. E. B. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02555-9 · Cited by 167
Insulin Resistance in Cushing’s Syndrome*
NOSADINI, R., DEL PRATO, S., TIENGO, A., VALERIO, A., MUGGEO, M., OPOCHER, G., MANTERO, F., DUNER, E., MARESCOTTI, C., MOLLO, F., et al. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-3-529 · Cited by 146
Serum lipid concentrations in patients with major depressive disorder
Olusi, S. O., & Fido, A. A. (1996) · Biological Psychiatry · doi:10.1016/s0006-3223(95)00599-4 · Cited by 144
Major depression and impaired glucose tolerance
Weber, B., Schweiger, U., Deuschle, M., & Heuser, I. (2000) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2000-7742 · Cited by 116
Self-citationDepression and anxiety symptoms in relation to anthropometry and metabolism in men
Ahlberg, A.-C., Ljung, T., Rosmond, R., McEwen, B. S., Holm, G., Åkesson, H. O., & Björntorp, P. A. (2002) · Psychiatry Research · doi:10.1016/s0165-1781(02)00192-0 · Cited by 112
Induction of the peroxisome proliferator activated receptor by fenofibrate in rat liver
Gebel, T., Arand, M., & Oesch, F. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80734-x · Cited by 106
Deuschle, M., Hamann, B., Meichel, C., Krumm, B., Lederbogen, F., Kniest, A., Colla, M., & Heuser, I. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200304000-00014 · Cited by 77
Self-citationKatsuki, A., Sumida, Y., Gabazza, E. C., Murashima, S., Urakawa, H., Morioka, K., Kitagawa, N., Tanaka, T., Araki-Sasaki, R., Hori, Y., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.6.8592 · Cited by 68
Relative insulin insensitivity and cortisol secretion in depressed patients
Nathan, R. S., Sachar, E. J., Asnis, G. M., Halbreich, U. M., & Halpern, F. S. (1981) · Psychiatry Research · doi:10.1016/0165-1781(81)90031-7 · Cited by 62
Cholesterol and psychological well-being
Wardle, J. (1995) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(94)00169-3 · Cited by 47
Ambrosch, A., Mühlen, I., Kopf, D., Augustus, W., Dierkes, J., König, W., Luley, C. H., & Lehnert, H. (1998) · Diabetes Care · doi:10.2337/diacare.21.12.2077 · Cited by 46
Self-citationIs serum cholesterol a biological marker for major depressive disorder?
Oxenkrug, G. F., Branconnier, R. J., Harto-Truax, N., & Cole, J. O. (1983) · American Journal of Psychiatry · doi:10.1176/ajp.140.7.920 · Cited by 36
Serum cholesterol and psychological distress in hospitalized depressed patients
Borgherini, G., Dorz, S., Conforti, D., Scarso, C., & Magni, G. (2002) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2002.00495.x · Cited by 30
Metabolic and physiologic consequences of nortriptyline treatment in the elderly.
Bg, P., Perel, J. M., Paradis, C. F., et al. (1994) · PubMed · Cited by 25
Flagged first, then by citations
Cited by
Sorted by citations
The interface of depression and obesity
Jantaratnotai, N., Mosikanon, K., Lee, Y., & McIntyre, R. S. (2017) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2016.07.003 · Cited by 282
Martino, M., Rocchi, G., Escelsior, A., & Fornaro, M. (2012) · Current Neuropharmacology · doi:10.2174/157015912800604542 · Cited by 111
Lipids in Psychiatric Disorders: Functional and Potential Diagnostic Role as Blood Biomarkers
Zorkina, Y., Ushakova, V., Ochneva, A., Tsurina, A., Abramova, O., Savenkova, V., Goncharova, A., Alekseenko, I., Morozova, I., Riabinina, D., et al. (2024) · Metabolites · doi:10.3390/metabo14020080 · Cited by 36
Metadata
- Authors
- Kopf, D., Westphal, S., Luley, C. W., Ritter, S., Gilles, M., Weber-Hamann, B., Lederbogen, F., Lehnert, H., Henn, F. A., Heuser, I., & Deuschle, M.
- Affiliations
- Central Institute of Mental Health (DE)
- Freie Universität Berlin (DE)
- Otto-von-Guericke-Universität Magdeburg (DE)
- Corresponding author
- Kopf, Daniel
- Ritter, Susanne
- Gilles, Maria
- Weber-Hamann, Bettina
- Lederbogen, Florian
- Henn, Fritz A.
- Deuschle, Michael
- Venue
- Journal of Clinical Psychopharmacology
- Published
- 2004-10
- Volume
- 24
- Issue
- 5
- Pages
- 527-531
- ISSN
- 0271-0749 (ISSN-L)
- OpenAlex
- W1976905142
- Cited by
- 92
- References
- 23
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 5 · 2022: 2 · 2020: 3 · 2019: 1 · 2018: 3 · 2017: 2 · 2016: 4 · 2015: 8 · 2014: 3 · 2013: 7 · 2012: 3
- FWCI
- 3.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- major depressive disorder, lipid metabolism, insulin resistance, cortisol, hypercortisolism, amitriptyline, paroxetine, lipoproteins, LDL cholesterol, HDL cholesterol, triglycerides, body mass index, obesity, cardiovascular risk, hypothalamic-pituitary-adrenal axis, QUICKI, cholesterol lowering
- MeSH terms
- Adult, Aged, Aged, 80 and over, Amitriptyline, Analysis of Variance, Antidepressive Agents, Blood Glucose, Cholesterol, Circadian Rhythm, Coronary Disease, Depressive Disorder, Major, Major Depressive Disorder, Female, Humans, Hydrocortisone, Hypothalamo-Hypophyseal System, Insulin Resistance, Lipids, Lipoproteins, Male, Middle Aged, Obesity, Pituitary-Adrenal System, Risk Factors, Triglycerides, Body Mass Index, Paroxetine, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review